Equine sFlt-1 antibody and antigen (recombinant protein)

Diagnostic anti-Equine sFlt-1 antibodies pairs and antigen for animal health (animal Equine/Horse ascular diseases and cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-sFlt-1-Ag01 Recombinant Equine sFlt-1 protein 3090
GMP-EQU-sFlt-1-Ab01 Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) 1953
GMP-EQU-sFlt-1-Ab02 Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) 1953
GMP-EQU-sFlt-1-Ab03 Anti-Equine sFlt-1 human monoclonal antibody (mAb) 1953
GMP-EQU-sFlt-1-Ab04 Anti-Equine sFlt-1 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-sFlt-1-Ag01
Product Name Recombinant Equine sFlt-1 protein
Target/Biomarker Equine soluble vascular endothelial growth factor receptor-1 (sFlt-1)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine soluble vascular endothelial growth factor receptor-1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sFlt-1 level test of animal Equine/Horse with ascular diseases and cancer.
Tag His
Products description Recombinant Equine sFlt-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-sFlt-1-Ab01, GMP-EQU-sFlt-1-Ab02
Product Name Anti-Equine sFlt-1 mouse monoclonal antibody (mAb)
Target/Biomarker Equine soluble vascular endothelial growth factor receptor-1 (sFlt-1)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine soluble vascular endothelial growth factor receptor-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies in sFlt-1 level test of animal Equine/Horse with ascular diseases and cancer.
Tag mFc
Products description Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-sFlt-1-Ab03, GMP-EQU-sFlt-1-Ab04
Product Name Anti-Equine sFlt-1 human monoclonal antibody (mAb)
Target/Biomarker Equine soluble vascular endothelial growth factor receptor-1 (sFlt-1)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine soluble vascular endothelial growth factor receptor-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies in sFlt-1 level test of animal Equine/Horse with ascular diseases and cancer.
Tag hFc
Products description Anti-Equine sFlt-1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Soluble Fms-Like Tyrosine Kinase-1 (sFlt-1) in horses (equines) is a pivotal biomarker with multifaceted roles in vascular health and angiogenesis regulation. It is a soluble receptor that plays a critical role in regulating the formation of new blood vessels (angiogenesis) and maintaining vascular homeostasis. Structurally, sFlt-1 is a truncated form of the transmembrane receptor, Fms-like tyrosine kinase-1 (Flt-1), which is involved in binding vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). In healthy adult horses, sFlt-1 levels are typically tightly regulated to contribute to the maintenance of normal vascular function. It serves as a decoy receptor, sequestering VEGF and PlGF and preventing them from binding to their cellular receptors. This regulation is crucial for preventing excessive angiogenesis and ensuring proper vascular function.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment